Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn12resultaten gevonden
Medicatieveiligheid

Specificity of medication surveillance (voorlopige titel)

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Jetske Graafsma
  • Promoters Patricia van den Bemt, Fatma Karapinar
  • Co-Promoters Joanna E. Klopotowska
  • Jaar 2024-2028
Medicatieveiligheid

Methylphenidate during pregnancy in women with ADHD

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Elvera Damer
  • Promoters E.N. van Roon
  • Co-Promoters P.G.J. ter Horst
  • Jaar 2023-2027
Medicatieveiligheid

Health Alliance for Prudent Prescription and Yield of Antibiotics in a Patient-centred Perspective (HAPPY PATIENT) – the role of community pharmacies

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Maarten Lambert
  • Promoters K. Taxis L. van Dijk
  • Jaar 2021-2025

European funded project to reduce the inappropriate use of antibiotics in common infectious diseases by implementing EU guidelines for the prudent use of antimicrobials in human health. Implementing the Audit Project Odense (APO) methodology in community pharmacies in 5 European countries (France, Spain, Lithuania, Poland and Greece).

Medicatieveiligheid

The role of the community pharmacist in diabetes care in Indonesia

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus I. Cahyaningsih
  • Promoters K. Taxis P. Denig
  • Jaar 2021-2025

How to expand the role of the community pharmacist in Indonesia in diabetes care. 
 

Medicatieveiligheid

Application of multinational pharmacoepidemiologic studies

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus C.O. Torre
  • Promoters K. Taxis I. Wong
  • Jaar 2021-2025

The research project aims to perform a multinational pharmacoepidemiologic study in order to examine the mental health effects of the COVID-19 pandemic across vulnerable groups, including people with established psychiatric disorders including dementia and neurodevelopmental disorders.

Medicatieveiligheid

Improving the collection and analysis of pregnancy pharmacovigilance data

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Y.R.J. van Rijt-Weetink
  • Promoters E.P. van Puijenbroek A.C.G. Egberts (RUU)
  • Co-Promoters F.P.A.M. van Hunsel
  • Jaar 2022-2026

Onderzoek naar de klinische kwaliteit van meldingen van mogelijke bijwerkingen bij blootstelling aan geneesmiddelen tijdens de zwangerschap en factoren die de aard van de gemelde bijwerkingen beïnvloeden.
 

Medicatieveiligheid

Optimizing therapy in patients suffering from statin-intolerance: n=1 trials.

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Ruben Mijnster
  • Promoters Hugo van der Kuy
  • Co-Promoters Melvin Lafeber Jeanine Roeters-van Lennep
  • Jaar 2024-2028

My research focuses on the occurence of nocebo-effects in statin-intolerant. We try to identify patients who are statin-intolerant and that suffer from these effects. We hope that by identifying patients affected by the nocebo effect and allowing them to experientially understand its impact through an N=1 study design, they will experience fewer side effects from their statin treatment. This may help prevent the need to switch to expensive PCSK9 inhibitors.
 

Pagina 1 van 2